Acurx Pharmaceuticals Inc is a biopharmaceutical company focused on developing novel antimicrobial therapies to combat bacterial infections, particularly those caused by antibiotic-resistant pathogens
The company is engaged in research and development of innovative drug candidates that address critical unmet medical needs in the treatment of serious infections. With a commitment to advancing therapeutic options, Acurx aims to improve patient outcomes through its proprietary drug formulations and scientific expertise. The company's efforts are geared toward not only treating existing infections but also preventing the spread of multidrug-resistant bacteria in healthcare settings.
STATEN ISLAND, NY / ACCESSWIRE / December 11, 2024 / Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company") (NASDAQACXP), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections, today announced that David P. Luci, President & Chief Executive Officer, will be presenting at The Microcap Conference, which will take place January 28 to January 30, 2025 at the Borgata Hotel, Atlantic City, New Jersey.
As Bitcoin (CRYPTO: BTC) hit a new all-time high of $98,310 on Thursday morning during European trading hours, he total net asset value of U.S. Bitcoin spot exchange-traded funds (ETFs) has exceeded $100 billion, a milestone achieved in just 10 months since their
New to The Street, the premier platform for introducing cutting-edge companies, is excited about Bloomberg TV's interviews which aired on Saturday, October 12, 2024 featured key industry leaders , sponsored by PetVivo Holdings Inc. (PETV), including: Zapp Electric Vehicles Group Limited (NASDAQZAPP), NUBURU (NYSEAM: BURU), Acurx Pharmaceuticals, Inc. NASDAQ: ACXPNASDAQACXP)
Shares of Alcoa Corporation (NYSEAA) rose sharply in today’s pre-market trading after the company reported better-than-expected sales for its first quarter.
The New to the Street TV series interviews are broadcast nationally on Bloomberg and Fox Business News, targeting investors. These segments offer a glimpse into companies spotlighted or soon to be featured on these networks.
Acurx Pharmaceuticals, Inc. (NASDAQACXP) stock may present an investment opportunity that is too good to ignore. That assessment is more than warranted; it's justified, based on results from its Phase 2b clinical trial of its lead antibiotic candidate, ibezapolstat, for treating patients with Clostridioides difficile Infection ( C. difficile, CDI). The data is more than compelling; it puts the target ACXP aims for, front-line treatment designation, in its crosshairs. And plenty supports hitting the bullseye.
Shares of Airspan Networks Holdings Inc. (NASDAQMIMO) shares rose sharply during Wednesday’s session after the company announced a partnership with GCT Semiconductor to develop an RF module. Airspan Networks Holdings shares surged 381% to $0.3699 on Wednesday.
